FDA and GlaxoSmithKline Warn Fosamprenavir (Lexiva) May Be Linked to...
... the French Hospital Database on HIV [FHDH ANRS CO4] has reported an association between exposure to fosamprenavir/amprenavir and an increased risk of myocardial infarction (Odds Ratio ...
HIV and Hepatitis,
Tue, 08 Dec 2009 02:50:50 GMT
• Found on Topix News
MI, Hypercholesterolemia Can Occur During Fosamprenavir Therapy
... According to the abstract , the risk of MI was increased by patients' cumulative exposure to fosamprenavir, amprenavir, or lopinavir. FDA-approved labeling for amprenavir, which GlaxoS...
ASHP,
Fri, 04 Dec 2009 01:30:31 GMT
• Found on Topix News